EPRS Admin By / February 7, 2019

EU health budget_GW

Future EU health budget in the 2021-2027 MFF

Figure 4 – Future EU health budget in the 2021-2027 MFF

The European Commission published its proposal for a new multiannual financial framework (MFF) for the 2021-2027 period, and for a new system of own resources (OR) on 2 May 2018. Under the new proposal, the European Social Fund Plus (ESF+) would serve as the EU’s main financial instrument for the implementation of the Social Pillar and would concentrate investment in education, employment and social inclusion, including healthcare. The ESF+ should merge the existing ESF, the Youth Employment Initiative (YEI), the FEAD, the EaSI and the health programme. The Commission proposes to allocate €101.2 billion in current prices (€89.7 billion in 2018 constant prices) from the EU budget to the ESF+.
In health policy
The current health programme will be embedded into the ESF+ as the ‘health strand’, with dedicated funding of €413 million. According to the Commission, integrating health in ESF+ is expected to complement other ESF+ activities that address the challenges identified in the European Semester, and will lead to synergies with the other building blocks of the Social Pillar. Financing for health-related activities would also be available through other EU financial instruments, notably Horizon Europe (under the ‘health’ cluster); the Digital Europe Programme (in one of the five ‘focus areas’); the European Regional Development Fund (ERDF); the InvestEU programme and the Emergency Aid Rescue (rescEU). According to the Commission, the health strand in ESF+ will provide means to test innovative solutions in a cross-border approach. It would focus on those areas in which EU cooperation has a proven benefit: improving crisis-preparedness and response to protect citizens against cross-border health threats; strengthening health systems by assisting health authorities in the digital transformation of health and care and in national reform processes; supporting EU health legislation, including on medicines, health technology assessment, tobacco and cross-border care; and supporting integrated work, for instance on rare diseases (via the European Reference Networks) or the implementation of best practices for health promotion and disease prevention.

Related Articles

Be the first to write a comment.

Leave a Reply